Cerebrospinal fluid levels of neurofilament light in chronic experimental autoimmune encephalomyelitis

N Norgren1, A Edelstam, T Stigbrand

  • 1Department of Immunology, University of Umeå, Sweden.

Brain Research Bulletin
|September 27, 2005
PubMed

Insights

This study shows that neurofilament light (NF-L) levels increase in rats with experimental autoimmune encephalomyelitis (EAE), an animal model for multiple sclerosis (MS). Monitoring NF-L in EAE can track disease progression and therapeutic responses.

Area of Science:

  • Neuroscience
  • Immunology
  • Biochemistry

Background:

  • Experimental autoimmune encephalomyelitis (EAE) serves as a chronic relapsing-remitting animal model for multiple sclerosis (MS).
  • Neurofilament light (NF-L) is a neuronal structural protein, valuable for quantifying neuronal damage in MS patients.

Purpose of the Study:

  • To measure neurofilament light (NF-L) levels in the cerebrospinal fluid (CSF) of rats with myelin oligodendrocyte glycoprotein (MOG)-induced EAE.
  • To investigate the correlation between NF-L levels and disease progression in this MS animal model.

Main Methods:

  • Induction of EAE in rats using myelin oligodendrocyte glycoprotein (MOG).
  • Measurement of NF-L levels in cerebrospinal fluid (CSF) using immunoassay.
  • Analysis of NF-L levels in spinal cord tissue via immunohistochemistry.

Main Results:

  • Significantly elevated NF-L levels were observed in MOG-immunized rats compared to control groups.
  • Increased NF-L turnover was indicated by elevated levels in the spinal cord of diseased animals.
  • Immunohistochemistry confirmed the increased presence and turnover of NF-L.

Conclusions:

  • Elevated NF-L levels in EAE rats mirror neuronal damage observed in MS patients.
  • NF-L serves as a reliable biomarker for monitoring disease progression in the EAE model.
  • Monitoring NF-L levels can aid in evaluating the efficacy of therapeutic interventions for MS.